(Q37801387)

23 August 2017

Atherosclerosis and sex hormones: current concepts (English)

1 reference

23 August 2017

1 reference

Amparo C Villablanca

1

1 reference

23 August 2017

Muthuvel Jayachandran

series ordinal

2

1 reference

23 August 2017

Carole Banka

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

119

1 reference

23 August 2017

12

1 reference

23 August 2017

493-513

1 reference

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

23 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Tracking women's awareness of heart disease: an American Heart Association national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

National study of women's awareness, preventive action, and barriers to cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Evidence-based guidelines for cardiovascular disease prevention in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Coronary arterial remodeling: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

The protective effects of estrogen on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Induction of calcium-dependent nitric oxide synthases by sex hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

The complex role of estrogens in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Atherosclerosis is an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

The molecular mechanisms of the thrombotic complications of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

From plaque biology to clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Prognostic value of coronary vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

A conserved mechanism for steroid receptor translocation to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

The unfolding stories of GPR30, a new membrane-bound estrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estrogen receptors: orchestrators of pleiotropic cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Unfolding the action of progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Cloning of Human Androgen Receptor Complementary DNA and Localization to the X Chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Human umbilical vascular endothelial cells express estrogen receptor beta (ERbeta) and progesterone receptor A (PR-A), but not ERalpha and PR-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Epitope-dependent localization of estrogen receptor-alpha, but not -beta, in en face arterial endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estrogen causes dynamic alterations in endothelial estrogen receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Vascular actions of estrogens: functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo : possible mechanisms for gender differences in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Tissue-specific effect of estradiol on endothelial cell-dependent lymphocyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Effects of estrogen, progesterone, and combination exposure on interleukin-1 beta-induced expression of VCAM-1, ICAM-1, PECAM, and E-selectin by human female iliac artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Response to sex hormones differs in atherosclerosis-susceptible and -resistant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Progesterone receptor subtypes in vascular smooth muscle cells of human aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Modulation of antioxidant enzyme expression and function by estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Tibolone and its metabolites induce antimitogenesis in human coronary artery smooth muscle cells: role of estrogen, progesterone, and androgen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

A Nuclear Receptor Atlas: macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Influence of surgical trauma on the mRNA expression of sex hormone receptors in PBMCs in male and female patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Androgen receptor-mediated inhibition of cutaneous wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Crossroads of estrogen receptor and NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Opposing effects of estradiol and progesterone on the oxidative stress-induced production of chemokine and proinflammatory cytokines in murine peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

The role of estrogen receptor subtypes for vascular maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

17beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estrogen prevents cholesteryl ester accumulation in macrophages induced by the HIV protease inhibitor ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17beta-estradiol fatty acyl esters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Minireview: estrogen and mouse models of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Catecholamines block the antimitogenic effect of estradiol on human coronary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Biomarkers of atherosclerotic plaque instability and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Biomarkers of premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Pilot study of sex differences in chemokine/cytokine markers of atherosclerosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: Genomics and proteomics approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Troponin: the biomarker of choice for the detection of cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

The Role of Biomarkers and Genetics in Peripheral Arterial Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Biomarkers of cardiovascular disease: molecular basis and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Basic mechanisms and pathogenesis of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Biologic nanoparticles and platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Purported nanobacteria in human blood as calcium carbonate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Microparticles in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Procoagulant microparticles: disrupting the vascular homeostasis equation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Microparticles and arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Role of microparticles in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Endothelial microparticles in diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Circulating microparticles: pathophysiology and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Apoptosis in atherosclerosis. Does it contribute to plaque instability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Vascular cell apoptosis in remodeling, restenosis, and plaque rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Loss of estrogen receptor beta decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Cardiovascular actions of selective estrogen receptor modulators and phytoestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Interactions of sex steroids with mechanisms of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Circulating mitochondrial DAMPs cause inflammatory responses to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

A critical review of fundamental controversies in the field of GPR30 research

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

In vivo functions of GPR30/GPER-1, a membrane receptor for estrogen: from discovery to functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

GPR30/GPER1: searching for a role in estrogen physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Cellular Origins and Thrombogenic Activity of Microparticles Isolated From Human Atherosclerotic Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

Identification of a splice variant of the rat estrogen receptor β gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100248

21 January 2018

Identifiers

DOI

10.1042/CS20100248

1 reference

23 August 2017

1 reference